Authors

Latest:

The Industry Insider: May 2007

News and information from the pharmaceutical industry. In this issue: 1) Multiple Deals for Affitech 2) Pfizer%u2019s Sutent Wins European Association of Urology Support 3) Aurora Breast MRI Will Meet Surge in Screening Demand, and more

By Querida Anderson

Latest:

The A-Z Business Wire

The latest business and financial biotech news. In this issue: 1) Adherex Buys Back GSK%u2019s Rights to Failed Cancer Drug 2) Archemix and Merck Partner on Aptamer-Based Cancer Therapeutics, and more

By Querida Anderson, Prachi Patel-Predd

Latest:

The Academy: April 2007

The Academy delivers the latest news on biotechnology and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing farther into knowledge and discovery.

By Querida Anderson, Prachi Patel-Predd, Nick Rose, Diane West,

Latest:

News Reports: May 2007

News items featured in this month's issue: 1) Preventive Health Exams May Lead to Cancer Screenings by Prachi Patel-Predd 2) Canine Cancer Vaccine Being Investigated for Use in Humans by Diane West 3) Antirejection Drug Shows Promise In Preventing Lung Cancer in Smokers by Diane West, and more

By Ralph de Vere White, MB, BCh, BAO

Latest:

Can Mouse Avatars Guide Cancer Treatment?

For patients battling a disease recurrence, results from tests in mice can translate to novel treatment approaches for individual cancer patients.

By Randall F. Holcombe, MD

Latest:

Developments in Metastatic Cancer

Over the past several years, several new approaches to treatment have prolonged and improved quality of life for patients with metastases.

By Rebecca Kronk, PhD, CRNP, MSN

Latest:

Promoting Sleep in Children With Cancer

Rebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.

By Robert Gamble

Latest:

Measuring Quality Cancer Care

The lack of attention in systematically measuring quality and value in cancer care became particularly obvious when working with the Oncology Medical Home Steering Committee on its objective of defining 16 quality, value, and outcome measures for cancer care.

By Robert Rowley, MD

Latest:

The Right System for the Right Price: To Avoid EHR Sticker Shock, You Have to See the Big Picture

The decision to move from a paper-based oncology practice to one based on an EHR system can be onerous and intimidating.

By Ronald Barkley, MS, JD

Latest:

Key Features of the CMMI Oncology Care Model (OCM)

To date, enthusiasm for bundled pricing has consisted principally of cardiac and orthopedic procedures with a hospital inpatient component. Is oncology next in line for alternate/bundled payment?

By Sandra Hanner

Latest:

Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients

Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially, for women with early breast cancer.

By Sandra Kear

Latest:

Advances in Preventing and Diagnosing Cervical Cancer

Advances in screening and the approval of vaccines against the human papillomavirus (HPV), which causes 70% of cervical cancer cases, have brought us to a turning point with cervical cancer.

By Sandra Spoelstra, PhD, RN

Latest:

Nurses Leading the Way: Promoting Adherence to Oral Cancer Medications

Sandra Spoelstra, PhD, RN, of the Michigan State University College of Nursing, outlines the essential and growing role of oncology nurses in helping patients with cancer to manage their oral regimens

By Sara L. Thier, PhD, MPH

Latest:

Complexities of Translating PD-1/PD-L1 Agents to Clinical Practice Emerge

As varying immunotherapy options become available for different types of cancers, researchers will have to take the next steps in clinical studies and in practice before the growing excitement over emerging agents can truly be translated into beneficial new therapies for patients.

By Sara Thier, PhD, MPH

Latest:

Experts Discuss New Diagnostic and Management Approaches in Multiple Myeloma

With the advent of safer and more effective treatments, early diagnosis of multiple myeloma (MM) has become an important goal.

By Stanton R. Mehr

Latest:

Reimbursement and Managed Care News: June 2007

Topics covered in this issue include: 1) High Cancer Drug Costs Altering the Research and Treatment Dynamic 2) $128 Million Settlement to Physicians 3) Coinsurance Change for Medicare Beneficiaries for Colon Cancer Screening, and more

By Steve Dobbs

Latest:

The Value of Office-Based Prescription Dispensing

Steve Dobbs, the CEO of Urologic Specialists of Oklahoma, Inc, discusses the viability, legality, and successful implementation of an office-based medication-dispensing solution.

By Stuart Lichtman, MD

Latest:

Individualized Approach to Treatment for the Elderly Ovarian Cancer Patient

Stuart Lichtman, MD, and William Tew, MD, from Memorial Sloan-Kettering Cancer Center, discuss personalizing treatment for elderly patients with ovarian cancer.

By Susan Krigel, PhD

Latest:

Chemobrain-It's Real, It's Complex, and the Science Is Still Evolving

Talk with almost any cancer survivor, and she/he is likely to bring up the topic of "chemobrain," that fuzzy, murky state that patients blame for impaired memory.

By Tony Hagen

Latest:

New Oncology Care Model Reforms Payment System, Offers Performance-Based Incentives

The CMS announced the launch of an Oncology Care Model that contains goals and incentives for practitioners in cancer care.